Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus

Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus

The incidence of left ventricular (LV) thrombi in the setting of an anterior myocardial infarction has declined significantly since the advent of primary percutaneous coronary intervention coupled with contemporary antithrombotic strategies in ST-segment elevation myocardial infarctions (STE-ACS). D...

Full description

Bibliographic Details
Main Authors: Rajeev Seecheran, Valmiki Seecheran MBBS, Sangeeta Persad MBBS, Naveen Anand Seecheran MBBS, MSc, FACC, FESC
Format: Article
Language:English
Published: SAGE Publishing 2017-03-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/2324709617697991

Internet

https://doi.org/10.1177/2324709617697991

Similar Items